Mahkota Medical Centre

SINGAPORE (Aug 31): The Edge Singapore last week reported that Health Management International (HMI) is among a clutch of SGX healthcare stocks that has outperformed the Straits Times Index last year.

SINGAPORE (Aug 29): Phillip Capital is maintaining its “buy” recommendation on Health Management International (HMI) at a target price of 83 cents, while expressing a positive view on the group’s FY18 earnings outlook.

SINGAPORE (Aug 28): OCBC Investment Research is maintaining its “buy” recommendation on Health Management International (HMI) with an unchanged fair value estimate of 80 cents.

SINGAPORE (March 15): Health Management International (HMI) announced that its recent renounceable non-underwritten 11-for-200 rights issue was 145.7% subscribed, raising gross proceeds of roughly $18.5 million.

SINGAPORE (Sept 15): KGI Fraser is initiating coverage on private healthcare operator Health Management International (HMI) with a “buy” call at a target price of 60 cents.

SINGAPORE (Aug 30): Maybank Kim Eng is highlighting Health Management International (HMI) as a “unique hospital operator” for its accelerating growth, healthy balance sheet, established track record and continued expansions.

SINGAPORE (Aug 25): Private hospital operator Health Management International (HMI) reported a 38% fall in fourth quarter earnings to RM4.87 million ($1.64 million) from a year ago due to higher expenses and costs.